Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

218P - Differential effects of estrogen exposure on steroid metabolizing CYP enzyme expression in estrogen receptor alpha versus beta positive breast cancer cell lines

Date

16 Sep 2021

Session

ePoster Display

Topics

Targeted Therapy;  Cancer Biology;  Pathology/Molecular Biology

Tumour Site

Breast Cancer

Presenters

Julia Stingl

Citation

Annals of Oncology (2021) 32 (suppl_5): S447-S456. 10.1016/annonc/annonc688

Authors

J.C. Stingl1, S. Jermar1, M. Hoffmann1, E. Stickeler2, J. Maurer2

Author affiliations

  • 1 Clinical Pharmacology, Universitaetsklinikum Aachen (UKA), 52074 - Aachen/DE
  • 2 Gynecology And Obstetrics, Universitaetsklinikum Aachen (UKA), 52074 - Aachen/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 218P

Background

Estrogen receptors (ER), ERα and ERβ, might serve as extra-hepatic regulators of CYP enzymes involved in steroid hormone metabolism such as CYP1B1, 1A1, 2B6, and CYP3A4. The aim of this project was, to study the responsiveness of either ERα negative and ERα positive cell lines on estrogen induced steroid metabolizing CYP enzyme expression, and changes in ERα or ERβ expression.

Methods

Two commercially available human breast cancer cell lines, which either expressed ERα or ERβ (T47D cells, ERα positive, and SKBR3 cells, ERα negative) were cultivated for gene expression analysis with different concentrations of 17-β estradiol (E2) in a range of 100 pM to 1000 nM for 24 hours. ERα protein expression (Isoforms 48 kDa and 66 kDa) was semiquantified by western blot analysis. The influence of E2 on CYP1B1, CYP2B6 and CYP3A4 expression on mRNA level was investigated by qPCR analysis using Lightcycler© realtime PCR technology.

Results

In both cell lines, CYP1B1 expression increased at higher E2 concentrations, but the induction was significant only in the ERα positive cell line. In the ERα positive cell line, CYP2B6 expression significantly decreased with increasing E2 concentrations indicating an inhibitory effect by E2. It was also investigated whether ER expression changes during estrogen exposure of the cells. In the ERα positive cell line, T47D, expression of ERβ, but not that of ERα, significantly increased after incubation with increasing E2 concentrations. In the ERα negative cell line, only ERβ was detected, and no changes in expression occurred after E2 treatment.

Conclusions

We detected differential effects of estrogen on CYP enzyme expression in ERα negative versus positive cell lines. While CYP1B1, the most prominent estrogen metabolizing enzyme showed a tendency to induction in both cell lines, CYP2B6 which is known to be induced by ERα, showed deceased expression levels at higher estrogen concentrations indicating a potential controversial effect mediated by ERβ, since expression of ERβ increased in the ERα positive cell line by estrogen incubation.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.